Substituted 1,3-dioxanes useful as PPAR modulators

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8536196
APP PUB NO 20100168169A1
SERIAL NO

12523843

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Specifically useful stereoisomers of 1,3-dioxane derivatives are described and their use in the treatment of a disease or condition dependent on PPAR modulation, such as diabetes, cancer, inflammation, neurodegenerative disorders and infections as well as their use in the treatment of a disease related to TP, such as cardiovascular diseases.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
EVOLVA SADUGGINGERSTRASSE 23 REINACH CH-4153

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Alberts, Peteris Helsingborg, SE 10 14
Bonnaud, Thierry Cambridge, GB 37 129
Crameri, Melya Hughes Los Altos, US 2 2
Kelleher, Joanne Dublin, IE 2 2
Mainkar, Prathama S Hyderabad, IN 5 6
Meyer, Jean-Philippe Strasbourg, FR 17 63
Pearson, David Royston, GB 59 499
Sorensen, Alexandra Santana Holte, DK 13 30

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Mar 17, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00